Terms: = Uterine cancer AND RAD21, HR21, 5885, ENSG00000164754, KIAA0078, FLJ25655, hHR21, MCD1, O60216, NXP1, HRAD21, FLJ40596, SCC1 AND Treatment
3 results:
1. Interference with XPO1 Suppresses the Stemness and Radioresistance of CD44 Positive Cervical cancer Cells via Binding with rad21.
Song G; Ren J; Li Y; Cui J
Ann Clin Lab Sci; 2023 Mar; 53(2):278-292. PubMed ID: 37094850
[TBL] [Abstract] [Full Text] [Related]
2. An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.
Romero I; Rubio MJ; Medina M; Matias-Guiu X; Santacana M; Schoenenberger JA; Guerra EM; Cortés A; Minig L; Coronado P; Cueva JF; Gómez L; Malfettone A; Sampayo M; Llombart-Cussac A; Poveda A
Gynecol Oncol; 2020 Dec; 159(3):721-731. PubMed ID: 32988624
[TBL] [Abstract] [Full Text] [Related]
3. Impact of Insurance Status on Radiation treatment Modality Selection Among Potential Candidates for Prostate, Breast, or Gynecologic Brachytherapy.
Grant SR; Walker GV; Koshy M; Shaitelman SF; Klopp AH; Frank SJ; Pugh TJ; Allen PK; Mahmood U
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):968-75. PubMed ID: 26452570
[TBL] [Abstract] [Full Text] [Related]
